Soluble ST2: a valuable prognostic marker in heart failure

被引：12
|
作者：
Savarimuthu, Sugeevan [1 ]
Goel, Pavan [2 ]
Harky, Amer [3 ]
机构：
[1] Basildon Hosp, Dept Med, Basildon, England
[2] Liverpool Heart & Chest Hosp, Dept Pharm, Liverpool, Merseyside, England
[3] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Liverpool, Merseyside, England
来源：
HEART FAILURE REVIEWS | 2022年 / 27卷 / 06期
关键词：
Heart failure; Soluble ST2; Natriuretic peptide; Biomarker; FAMILY-MEMBER ST2; GALECTIN-3; SUPPRESSION; BIOMARKER; SST2;
D O I：
10.1007/s10741-022-10258-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Natriuretic peptides have been at the forefront of biomarker use in heart disease and have been universally recommended as the ideal biomarker in the setting of heart failure. Soluble ST2 is one such biomarker which has found value as a prognostic marker and can be used individually or along with natriuretic peptides in order to prognosticate patients with heart failure. Leading cardiovascular organisations have recognised this biomarker, though its role as a diagnostic marker is yet to be determined. We aim to investigate the role of sST2 in heart failure in the existing literature.
引用
收藏
页码：2155 / 2164
页数：10
相关论文
共 50 条
  • [21] Soluble ST2 in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Dunlay, Shannon M.
    Stevens, Susanna R.
    Felker, G. Michael
    Borlaug, Barry A.
    Chen, Horng H.
    Tracy, Russell P.
    Braunwald, Eugene
    Redfield, Margaret M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02):
  • [22] Monitoring of chronic heart failure with serum soluble ST2
    Piper, S.
    Hipperson, D.
    Decourcey, J.
    Sherwood, R.
    Amin-Youssef, G.
    Mcdonagh, T. A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S224 - S224
  • [23] Soluble ST2 and Galectin-3 in Heart Failure
    Shah, Ravi V.
    Januzzi, James L., Jr.
    [J]. CLINICS IN LABORATORY MEDICINE, 2014, 34 (01) : 87 - +
  • [24] Soluble ST2 reflects hemodynamic stress in heart failure
    Broch, K.
    Sharma, G.
    Ueland, T.
    Aukrust, P.
    Aakhus, S.
    Gullestad, L.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 1091 - 1092
  • [25] Role of Soluble ST2 as a Marker for Rejection after Heart Transplant
    Lee, Ga Yeon
    Choi, Jin-Oh
    Ju, Eun-Seon
    Lee, Yoo-Jung
    Jeon, Eun-Seok
    [J]. KOREAN CIRCULATION JOURNAL, 2016, 46 (06) : 811 - 820
  • [26] Prognostic value of soluble ST2 in adults with congenital heart disease
    Geenen, Laurie W.
    Baggen, Vivan J. M.
    van den Bosch, Annemien E.
    Eindhoven, Jannet A.
    Cuypers, Judith A. A. E.
    Witsenburg, Maarten
    Boersma, Eric
    Roos-Hesselink, Jolien W.
    [J]. HEART, 2019, 105 (13) : 999 - 1006
  • [27] Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis
    Dispenzieri, Angela
    Saenger, Amy K.
    Kumar, Shaji K.
    Gertz, Morie A.
    Lacy, Martha Q.
    Buadi, Francis
    Hayman, Suzanne R.
    Leung, Nelson
    Zeldenrust, Steven R.
    McCurdy, Arleigh
    Kyle, Robert
    Dingli, David
    Kapoor, Prashant
    Lin, Yi
    Russell, Stephen J.
    Go, Ronald S.
    Jaffe, Allan S.
    [J]. BLOOD, 2013, 122 (21)
  • [28] Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome
    Kopeva, K.
    Grakova, E., V
    Yakovlev, A., V
    Shilov, S. N.
    Yakovleva, N. F.
    Berezikova, E. N.
    Teplyakov, A. T.
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2021, 20 : 132 - 132
  • [29] BIOLOGICAL VARIABILITY OF SOLUBLE ST2 IN STABLE CHRONIC HEART FAILURE
    Piper, Susan
    Hipperson, Doma
    deCourcey, Julia
    Sherwood, Roy
    Amin-Youssef, Ajay Shah George
    McDonagh, Theresa
    [J]. HEART, 2014, 100 : A29 - A29
  • [30] ST2 in Heart Failure: Where Does This New Marker Fit in?
    Mallick, Aditi
    Januzzi, James L.
    [J]. CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2015, 3 (02): : 55 - 61
12345